EMA Authorised: Twinrix Paediatric (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.

View source ↗

Summary

The EMA has authorised Twinrix Paediatric, a combined hepatitis A and B vaccine for children, under the marketing authorization holder GlaxoSmithKline Biologica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A
• Hepatitis B

Drugs mentioned

• Twinrix Paediatric (hepatitis A virus (inactivated);hepatitis B surface antigen)

Snippet

Status: Authorised. Therapeutic area: Immunization;Hepatitis B;Hepatitis A. MAH: GlaxoSmithKline Biologicals S.A.. Decision date: 29/07/2026